Trials / Sponsors / Gylden Pharma Ltd
Gylden Pharma Ltd
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Phase I Study of PepGNP-ChikV in Healthy Volunteers Chikungunya, Chikungunya Fever, Chikungunya Virus Infection | EARLY_Phase 1 | 2026-08-03 |
| Not Yet Recruiting | Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19) Coronavirus, SARS-CoV-2 Infection, COVID-19 | Phase 1 / Phase 2 | 2025-09-01 |
| Completed | A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against SARS-CoV-2 Coronavirus, SARS-CoV-2 Infection, COVID-19 | Phase 1 | 2022-01-10 |
| Completed | A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against Dengue Virus Dengue | Phase 1 | 2021-08-02 |